Delivery Order SPE2DB22D2009-SPE2DB26FL5ZU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,252.48 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors on October 28, 2025, with completion targeted for October 29, 2025. This non-competitive delivery order carries firm fixed pricing and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen Drug Corp...
- The Defense Logistics Agency awarded a $3,109.35 delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 ml pen injections. This is a firm fixed price, non-set-aside contract with an ultimate completion date of May 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $12,551.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 ml pen injectors on September 16, 2025, with completion scheduled for September 17, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's pharmaceutical supply role within the federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,482.82 to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pen injectors with an ultimate completion date of August 12, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 15 mg/0.5 mL pens on September 15, 2025. This firm fixed-price, non-set-aside delivery order, which is due for completion by September 16, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the federal government. The product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,245.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 5 mg/0.5 mL pen injectors on September 17, 2025, with an ultimate completion date of September 18, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single transaction within AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,170.98 to AmerisourceBergen Drug Corp for the supply of Mounjaro (tirzepatide) 12.5 mg/0.5 mL pen injections on August 29, 2025, with completion scheduled for September 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $26,703 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen injectors with an ultimate completion date of September 19, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical prime vendor agreement running through...
- The Defense Logistics Agency awarded a $2,978.46 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 10 mg/0.5 mL pens on October 22, 2025, with completion targeted for October 23, 2025. This non-set-aside competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the contractor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $3,265.08 delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 15 mg/0.5 mL pen injectors on October 30, 2025, with completion required by October 31, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply agreement with DLA. The award is classified as a child contract, indicating it derives from a larger indefinite delivery vehicle....
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB26FL5ZUDelivery Order
The Defense Logistics Agency awarded a $2,344.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 2.5 mg/0.5 mL pen injectors on October 28, 2025, with completion scheduled for October 29, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. AmerisourceBergen Drug Corp serves as a critical federal vendor for military and veteran healthcare systems through the DLA's Medical Supply Chain network. The company's broader IDC portfolio encompasses a comprehensive range of pharmaceuticals and medical supplies spanning multiple therapeutic domains, including diabetes medications, neurological treatments, pain management drugs, antibiotics, and specialty medical devices. This delivery order for Mounjaro supports ongoing federal healthcare procurement needs and reflects AmerisourceBergen's competitive positioning as a primary pharmaceutical supplier to the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 10/28/25 |